xiaohua li
xiaohua li
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer | Rcctal Cancer | Recruiting | Phase 2 | 2025-02-05 | NCT06808412 | |
| A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab | gastroesophageal junction adenocarcinoma | Active, not recruiting | Phase 2 | 2024-11-08 | NCT06681298 | |
| The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric carcinoma, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not stated | 2024-11-08 | NCT06680362 | |
| Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer: | Gastroesophageal Junction Cancer | Not yet recruiting | Phase 3 | 2024-05-17 | NCT06411171 |